Onderneming Revive Therapeutics Ltd Toronto S.E.
Aandelen
RVV
CA7615161030
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- CAD | -.--% | +6,67% | -11,11% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18-12-19 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18-12-19 |
William Jackson
BRD | Director/Board Member | - | 01-01-14 |
Andrew Lindzon
BRD | Director/Board Member | 63 | 18-12-19 |
Director/Board Member | 50 | 18-12-19 | |
Joshua Herman
BRD | Director/Board Member | - | 18-12-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 418 564 269 | 412 444 735 ( 98,54 %) | 0 | 98,54 % |
Bedrijfsgegevens
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,42% | 114 mld. | |
+11,84% | 104 mld. | |
-14,15% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,16% | 17,89 mld. | |
+7,99% | 14,28 mld. | |
+36,24% | 12,55 mld. |